Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center.
Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center.
Can J Cardiol. 2018 Dec;34(12):1648-1654. doi: 10.1016/j.cjca.2018.10.002. Epub 2018 Oct 13.
We sought to identify nontraditional risk factors coded in administrative claims data and evaluate their ability to improve prediction of long-term mortality in patients undergoing percutaneous mitral valve repair.
Patients undergoing transcatheter mitral valve repair using MitraClip implantation between September 28, 2010, and September 30, 2015 were identified among Medicare fee-for-service beneficiaries. We used nested Cox regression models to identify claims codes predictive of long-term mortality. Four groups of variables were introduced sequentially: cardiac and noncardiac risk factors, presentation characteristics, and nontraditional risk factors.
A total of 3782 patients from 280 clinical sites received treatment with MitraClip over the study period. During the follow-up period, 1114 (29.5%) patients died with a median follow-up time period of 13.6 (9.6 to 17.3) months. The discrimination of a model to predict long-term mortality including only cardiac risk factors was 0.58 (0.55 to 0.60). Model discrimination improved with the addition of noncardiac risk factors (c = 0.63, 0.61 to 0.65; integrated discrimination improvement [IDI] = 0.038, P < 0.001), and with the subsequent addition of presentation characteristics (c = 0.67, 0.65 to 0.69; IDI = 0.033, P < 0.001 compared with the second model). Finally, the addition of nontraditional risk factors significantly improved model discrimination (c = 0.70, 0.68 to 0.72; IDI = 0.019, P < 0.001, compared with the third model).
Risk-prediction models, which include nontraditional risk factors as identified in claims data, can be used to predict long-term mortality risk more accurately in patients who have undergone MitraClip procedures.
我们旨在确定在行政索赔数据中编码的非传统危险因素,并评估其在预测行经皮二尖瓣修复术患者的长期死亡率方面的能力。
在 2010 年 9 月 28 日至 2015 年 9 月 30 日期间,我们在 Medicare 按服务收费受益人群中确定了接受经导管二尖瓣修复术(使用 MitraClip 植入术)的患者。我们使用嵌套 Cox 回归模型来确定预测长期死亡率的索赔代码。我们依次引入了四组变量:心脏和非心脏危险因素、表现特征和非传统危险因素。
在研究期间,共有 3782 例患者来自 280 个临床中心接受了 MitraClip 治疗。在随访期间,有 1114 例(29.5%)患者死亡,中位随访时间为 13.6(9.6 至 17.3)个月。仅包含心脏危险因素的预测长期死亡率模型的区分度为 0.58(0.55 至 0.60)。模型区分度随着非心脏危险因素的增加而提高(c=0.63,0.61 至 0.65;综合鉴别改善[IDI] = 0.038,P<0.001),随着表现特征的随后增加而提高(c=0.67,0.65 至 0.69;IDI=0.033,与第二个模型相比,P<0.001)。最后,非传统危险因素的加入显著提高了模型的区分度(c=0.70,0.68 至 0.72;IDI=0.019,P<0.001,与第三个模型相比)。
包含索赔数据中确定的非传统危险因素的风险预测模型可更准确地预测接受 MitraClip 手术的患者的长期死亡率风险。